Pacific Biosciences Of California (PACB) Property, Plant & Equipment (Net) Growth (1y) (2011 - 2026)
Pacific Biosciences Of California (PACB) Property, Plant & Equipment (Net) Growth (1y) (2011 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PP&E (Net) Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.63 Bn | 194.02 Bn | 7.27 Bn | 12.44% |
| 2 | Stryker | 127.42 Bn | 123.95 Bn | 4.50 Bn | 6.92% |
| 3 | Medtronic | 118.97 Bn | 109.75 Bn | 6.41 Bn | 8.48% |
| 4 | Boston Scientific | 73.39 Bn | 72.85 Bn | 3.85 Bn | 19.21% |
| 5 | Edwards Lifesciences | 51.97 Bn | 47.72 Bn | 1.35 Bn | 6.67% |
| 6 | Dexcom | 34.32 Bn | 32.37 Bn | 830.00 Mn | 8.23% |
| 7 | GE HealthCare Technologies | 33.76 Bn | 31.65 Bn | 2.18 Bn | 6.21% |
| 8 | Koninklijke Philips | 26.35 Bn | 23.03 Bn | 4.55 Bn | -1.40% |
| 9 | Steris | 23.04 Bn | 22.56 Bn | 684.20 Mn | 5.69% |
| 10 | Pacific Biosciences Of California | 396.09 Mn | 159.21 Mn | 12.64 Mn | 16.75% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 16.75% |
| Mar 31, 2026 | -1.69% |
| Dec 31, 2025 | -20.85% |
| Sep 30, 2025 | -30.75% |
| Jun 30, 2025 | -33.82% |
| Mar 31, 2025 | -33.51% |
| Dec 31, 2024 | -16.27% |
| Sep 30, 2024 | -20.79% |
| Jun 30, 2024 | -13.41% |
| Mar 31, 2024 | -8.67% |
| Dec 31, 2023 | -12.38% |
| Sep 30, 2023 | 3.03% |
| Jun 30, 2023 | 6.22% |
| Mar 31, 2023 | 14.99% |
| Dec 31, 2022 | 27.92% |
| Jun 30, 2022 | 51.83% |
| Mar 31, 2022 | 46.69% |
| Dec 31, 2021 | 30.54% |
| Jun 30, 2021 | -9.85% |
| Mar 31, 2021 | -16.75% |